Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001741830-25-000018
Filing Date
2025-04-25
Accepted
2025-04-25 16:11:23
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A kron-20241231.htm   iXBRL 10-K/A 353603
2 EX-31.2 ex312kron10-ka12312024.htm EX-31.2 4906
  Complete submission text file 0001741830-25-000018.txt   899606

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20241231.xsd EX-101.SCH 2541
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20241231_lab.xml EX-101.LAB 138414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20241231_pre.xml EX-101.PRE 74807
21 EXTRACTED XBRL INSTANCE DOCUMENT kron-20241231_htm.xml XML 11198
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39592 | Film No.: 25874078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)